Number of Shares
347,408.00
Current Holdings Value*
$11.66 Mil
% of Portfolio
0.13%
Total Estimate Gain
$17.19 Mil
% of Total Estimate Gain
86.73%

BAKER BROS. ADVISORS LP's Xenon Pharmaceuticals Inc Holding Summary

As of 2025-03-31, BAKER BROS. ADVISORS LP held 347,408.00 shares of Xenon Pharmaceuticals Inc(XENE), totaling $11.66 Mil. This investment constitutes 0.13% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 0.45% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.

The initial trade took place in 2020Q2. And since then BAKER BROS. ADVISORS LP has made 3 purchases of XENE, at an average price of $17.93, for a total of 1.11 Mil shares. In addition, there have been 3 sales at an average price of $34.10 for 757,987.00 shares. Based on historical transaction data and XENE's current price of $32.12, BAKER BROS. ADVISORS LP's estimated gain on his XENE holdings is $17.19 Mil, reflecting a 86.73% gain to date.

BAKER BROS. ADVISORS LP XENE ($32.12) Holding Chart

BAKER BROS. ADVISORS LP XENE ($32.12) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1